Olin Corporation manufactures and distributes chemical products across the United States, Europe, Asia Pacific, the Middle East, Africa, India, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine, caustic soda, ethylene dichloride, vinyl chloride monomers, and other chlorinated organics. The Epoxy segment provides allylics, aromatics, bisphenol, epoxy resins, and additives. The Winchester segment offers sporting ammunition, small caliber military ammunition, and industrial products. The company markets through its sales force and directly to industrial customers, mass merchants, retailers, wholesalers, gun clubs, distributors, and the U.S. Government. Olin Corporation was incorporated in 1892 and is based in Clayton, Missouri.
Olin's merger advances, but weak chemicals demand and a surprise loss weigh on the stock
▲
Olin-Huntsman merger approved by shareholders Shareholders overwhelmingly approved the all-stock merger with Huntsman, creating a $12.5 billion chemicals company. The deal promises over $400 million in cost savings, which could boost future profits and support the stock. It is expected to close in the first half of 2027, pending regulatory approval.
This is the latest major step in the merger and directly affects OLN's future value.
▼
Surprise Q2 loss and 16% stock drop Olin reported a surprise loss of $0.12 per share, missing expectations for a profit, and revenue fell short. The stock dropped about 16% in one day. Weak chlor alkali sales and merger-related costs drove the loss, showing the company's core business is struggling.
This is a new negative event that directly caused a sharp price decline and reflects fundamental weakness.
▲
Chlor-alkali market tightening could lift Olin Hotchkis & Wiley sees North American chlor-alkali supply and demand tightening over the next five-plus years, which could raise prices and volumes. As the region's swing producer, Olin could benefit more than peers. This long-term trend offers a potential recovery path.
This is a new analyst view on a key market driver that could improve Olin's future earnings.
◆
Merger synergies valued, but integration costs and risks remain UBS estimates the merger's cost savings could add $8–$11 per share in value, mainly from procurement, operations, and overhead cuts. However, the deal also brings $10.6 million in acquisition costs and execution risk, and it does not expand into new markets, so the benefit depends on successful integration.
This explains the financial rationale and potential value of the merger, a key driver for OLN.
Q3 2026
▲2▼1
Olin's merger advances, but weak chemicals demand and a surprise loss weigh on the stock
▲
Olin-Huntsman merger approved by shareholders Shareholders overwhelmingly approved the all-stock merger with Huntsman, creating a $12.5 billion chemicals company. The deal promises over $400 million in cost savings, which could boost future profits and support the stock. It is expected to close in the first half of 2027, pending regulatory approval.
This is the latest major step in the merger and directly affects OLN's future value.
▼
Surprise Q2 loss and 16% stock drop Olin reported a surprise loss of $0.12 per share, missing expectations for a profit, and revenue fell short. The stock dropped about 16% in one day. Weak chlor alkali sales and merger-related costs drove the loss, showing the company's core business is struggling.
This is a new negative event that directly caused a sharp price decline and reflects fundamental weakness.
▲
Chlor-alkali market tightening could lift Olin Hotchkis & Wiley sees North American chlor-alkali supply and demand tightening over the next five-plus years, which could raise prices and volumes. As the region's swing producer, Olin could benefit more than peers. This long-term trend offers a potential recovery path.
This is a new analyst view on a key market driver that could improve Olin's future earnings.
◆
Merger synergies valued, but integration costs and risks remain UBS estimates the merger's cost savings could add $8–$11 per share in value, mainly from procurement, operations, and overhead cuts. However, the deal also brings $10.6 million in acquisition costs and execution risk, and it does not expand into new markets, so the benefit depends on successful integration.
This explains the financial rationale and potential value of the merger, a key driver for OLN.
News & notes movingOLN
United States
Cloud & Digital Infrastructure▼
Twilio to Join S&P 500 as S&P Dow Jones Reshuffles Indices
S&P Dow Jones Indices announced a series of benchmark rebalancings on Thursday afternoon, effective prior to the market open on Tuesday, Oct. 6. Cloud communications software maker Twilio Inc Class A will join the flagship S&P 500, moving up from the S&P MidCap 400, replacing Warner Bros Discovery Inc, which is being acquired by S&P 500 constituent Paramount Skydance Corp in a deal nearing final completion. Twilio shares rose 1.6% in extended trading, while semiconductor test equipment producer FormFactor Inc will fill Twilio's former spot in the S&P MidCap 400 as it shifts up from the S&P SmallCap 600. The small-cap benchmark will in turn absorb SaaS platform Workiva Inc, which replaces FormFactor and gained 2.7% after-hours. In a separate structural shift, newly formed Consumer Staples entity Vylor Inc. joined the S&P 500 on Thursday following its spinoff from Corteva Inc, which will transition into the S&P MidCap 400 on Oct. 6, taking the spot of Olin Corporation; Olin moves to the S&P SmallCap 600 to replace chipmaker Qorvo Inc, which is being acquired by Skyworks Solutions Inc in a pending transaction that prompted the chain of small-cap reallocations.
Citi downgrades Dow and LyondellBasell to Neutral on weak chemical demand
Citi downgraded Dow and LyondellBasell to Neutral from Buy on Wednesday, citing weak demand that is limiting the benefit chemical producers might otherwise receive from higher oil and global feedstock costs. Lead analyst Patrick Cunningham said Citi no longer has conviction that polyethylene prices offer significant upside, even with crude oil at $100 a barrel, and the firm cut earnings estimates and price targets across much of its North American commodity chemicals coverage. Citi lowered its Dow price target to $30 from $35 and its LyondellBasell target to $63 from $72, and reduced its 2027 EPS estimate for Dow to $1.21 from $1.83 and for LyondellBasell to $5.79 from $7.20. The firm expects integrated polyethylene margins to decline by about 11 cents per pound in 2027, with each 1-cent change representing roughly $120 million in annualized EBITDA for Dow's North American operations and $133 million for LyondellBasell. Citi also cut its Westlake price target to $67 from $85 while maintaining a Neutral rating, trimmed its Celanese target to $58 from $60 and its Eastman Chemical target to $76 from $81 while keeping Buy ratings on both, and maintained Neutral/High Risk ratings on Huntsman and Olin with price targets cut to $9 from $11 and $17 from $19, respectively.
DOW · Capital · Negative Citi downgraded Dow to Neutral from Buy and cut its price target to $30 from $35 and 2027 EPS estimate to $1.21 from $1.83.
LYB · Capital · Negative Citi downgraded LyondellBasell to Neutral from Buy and cut its price target to $63 from $72 and 2027 EPS estimate to $5.79 from $7.20.
CE · Capital · Negative Citi trimmed its Celanese price target to $58 from $60 while keeping a Buy rating.
EMN · Capital · Negative Citi cut its Eastman Chemical price target to $76 from $81 while keeping a Buy rating.
HUN · Capital · Negative Citi maintained a Neutral/High Risk rating on Huntsman and cut its price target to $9 from $11.
OLN · Capital · Negative Citi maintained Neutral/High Risk on Olin and cut its price target to $17 from $19 amid weak chemical demand.
Olin and Huntsman Merger Clears HSR Antitrust Waiting Period
Olin Corporation and Huntsman Corporation announced that the waiting period under the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired for their pending merger of equals, satisfying one of the key closing conditions. Shareholders of both companies overwhelmingly approved the transaction on August 25, 2026. The closing remains subject to customary closing conditions, including receipt of additional regulatory approvals that are already underway. Huntsman reported 2025 revenues of approximately $6 billion from continuing operations and operates more than 55 manufacturing, R&D and operations facilities in approximately 25 countries with roughly 6,000 associates. Olin is a vertically integrated global chemical manufacturer and a leading U.S. ammunition maker through its Winchester business.
HUN · Capital · Positive HSR antitrust waiting period expired and shareholders approved the merger of equals, advancing a key closing condition for Huntsman.
OLN · Capital · Positive HSR antitrust waiting period expired and shareholders approved the merger of equals, advancing a key closing condition for Olin.
Olin and Huntsman Shareholders Approve All-Stock Merger
Olin Corporation and Huntsman Corporation have received overwhelming shareholder approval for their all-stock merger of equals, creating OlinHuntsman Corporation, a leading North American integrated chemicals producer. At Olin's special meeting, approximately 97% of votes cast, representing 81% of outstanding shares, supported the deal, while Huntsman saw roughly 99% of votes cast, representing 75% of outstanding shares, in favor. The combined company is expected to have about $12.5 billion in 2025 revenues and a broader manufacturing footprint across North America, Europe, and Asia. The merger is projected to deliver more than $400 million in total cost synergies and integration benefits, including over $300 million from purchasing efficiencies, raw material integration, operational optimization, and SG&A savings, plus an additional $100 million in raw material integration benefits beginning in 2031 and about $125 million in cash tax benefits. The transaction is expected to close in the first half of 2027, subject to regulatory approvals and other customary conditions.
Olin Q2 adjusted earnings meet estimates, revenue beats on Epoxy and Winchester strength
Olin Corporation reported second-quarter adjusted earnings of 7 cents per share, in line with the Zacks Consensus Estimate, while revenue beat expectations. Revenue declined 0.9% year over year to $1,741.9 million but surpassed the consensus estimate of $1,719.6 million by 1.3%. Adjusted EBITDA rose 8.6% to $191.3 million, supported by improved chemical pricing and stronger performance in the Epoxy and Winchester segments. Epoxy sales increased 27.4% to $422.1 million and Winchester sales rose 11.8% to $500.3 million, both exceeding consensus estimates, while Chlor Alkali Products and Vinyls sales fell 16.3% to $819.5 million, missing expectations. For the third quarter of 2026, Olin expects adjusted EBITDA between $160 million and $200 million, with a roughly $20 million impact from a disruption at its Freeport vinyl chloride monomer facility.
Monteverde & Associates investigates mergers of Planet 13, Olin, Huntsman, and First Seacoast
Monteverde & Associates PC, a class action firm, is investigating four proposed mergers. Planet 13 Holdings Inc. is merging with Vireo Growth Inc., with Planet 13 shareholders expected to receive 0.015383618 shares of Vireo for each Planet 13 share. Olin Corporation is merging with Huntsman Corporation, and Olin shareholders will own approximately 54.5% of the combined company, with a shareholder vote scheduled for August 25, 2026. Huntsman Corporation is being sold to Olin Corporation, and Huntsman shareholders are expected to receive 0.5476 shares of Olin for each Huntsman share, also with a vote on August 25, 2026. First Seacoast Bancorp, Inc. is being sold to Cambridge Financial Group, Inc., and First Seacoast shareholders are expected to receive $17.25 per share in cash, with a shareholder vote scheduled for August 27, 2026.
FSEA · Capital · Positive Acquired for $17.25 per share in cash, a premium to market.
HUN · Capital · Positive Being acquired by Olin, shareholders receive 0.5476 Olin shares per share.
OLN · Capital · Positive Merging with Huntsman, shareholders will own 54.5% of combined company.
Planet 13 Holdings Inc. · Capital · Positive Being acquired by Vireo, shareholders receive 0.015383618 Vireo shares per share.
Vireo Growth Inc. · Capital · Positive Acquiring Planet 13 in a stock-for-stock merger.
Cambridge Financial Group, Inc. · Capital · Positive Acquiring First Seacoast Bancorp for $17.25 per share in cash is a positive M&A deal for Cambridge Financial Group.
Hotchkis & Wiley says chlor-alkali tightening could drive Olin recovery
Hotchkis & Wiley's Mid-Cap Value Fund highlighted Olin Corporation as a detractor in the second quarter of 2026, but sees a tightening North American chlor-alkali supply/demand outlook over the next five-plus years that could drive a pricing and volume recovery. The fund noted that Olin, one of the largest global producers of chlor alkali chemicals and chlorine derivatives and owner of the Winchester ammunition brand, is significantly underearning due to below-normal commodity prices and demand. As the swing producer in the region, Olin could capture more than its share of the improvement, with shareholder-friendly capital allocation and an investment-grade balance sheet commitment reinforcing the case. The stock's decline reflects an easing of Middle East tensions that will loosen near-term supply/demand dynamics, while Olin also announced a merger of equals with Huntsman that the fund views as strategically sound and likely to reduce risk through synergy capture and deleveraging. Olin shares closed at $18.62 on August 3, 2026, with a one-month return of negative 10.22% and a 52-week loss of 2.05%, giving it a market capitalization of $2.12 billion.
Olin posts Q2 loss and 16% one-day stock drop, yet narrative sees 30% upside
Olin Corporation reported a net loss in its second quarter 2026 earnings, triggering a one-day share price decline of about 16%. The stock's 90-day return is down 35.3%, and its three-year total shareholder return stands at negative 66%. Despite the losses and operational challenges including the Freeport VCM outage, a widely followed narrative estimates Olin's fair value at $26.29 per share, implying the stock is 29.6% undervalued relative to its last close of $18.51. That valuation relies on structural cost reductions from the Beyond250 and Epoxy programs, expected to deliver $70–90 million in annual run-rate benefits by the end of 2025, plus additional savings from the Stade, Germany facility in 2026. Key risks to the recovery story include global overcapacity pressuring chlor alkali pricing and ongoing margin strain in the Winchester ammunition business.
Huntsman Posts Narrower Q2 Loss, Reaffirms Olin Merger with $300 Million Synergy Target
Huntsman Corporation reported second-quarter 2026 sales of US$1,663 million and a net loss of US$6 million, an improvement from prior losses, and declared a US$0.0875 per share cash dividend payable on September 30, 2026 to shareholders of record on September 15, 2026. The company also reaffirmed its proposed merger with Olin, highlighting an expected US$300 million in synergies and additional benefits after a key chlorine supply contract expires, reinforcing its push toward higher-margin specialty products and efficiency gains. The reaffirmed merger remains the central catalyst for Huntsman's strategy, with management emphasizing specialty products and efficiency against risks of overcapacity, weak housing demand, and high European costs.
Olin stock is trading around US$18.51 after a three-year decline of roughly 66%, yet valuation checks suggest the company screens cheaply relative to its fundamentals. The planned all-stock merger with Huntsman could support a larger chemicals platform, though a recent unplanned shutdown at a vinyl chloride monomer plant highlights operational risks. On Simply Wall St's assessment, Olin is undervalued in five of six areas, and its price-to-sales multiple of about 0.3x sits well below the Chemicals industry average of roughly 1.1x and an implied fair ratio of about 0.8x. The key question is whether the current price already reflects merger-related risks and recent losses, or if Olin still offers material upside based on its underlying valuation.
Olin Corp Stock Tumbles 17.8% After Surprise Quarterly Loss
Shares of Olin Corp dropped 17.8% through 11:35 a.m. ET Friday after the chemicals and ammunition maker reported a surprise second-quarter loss. Analysts had expected earnings of $0.12 per share on $1.8 billion in sales, but Olin posted a loss of $0.12 per share on $1.7 billion in revenue. The company, which is in the process of a merger of equals with Huntsman, saw sales decline 14% in its Chlor Alkali Products and Vinyls segment, while Epoxy sales grew 27% and Winchester ammunition sales rose 12%. Overall sales slipped just 1% year over year, but losses widened to $0.12 per share from $0.01 a year ago, partly due to $10.6 million in acquisition-related costs tied to the pending merger. The merger is expected to close in early 2027.
Olin Q2 revenue reaches $1.74 billion, beating estimates by 1.3%
Olin reported second-quarter revenue of $1.74 billion, a 0.9% decline from a year earlier but 1.3% above the Zacks Consensus Estimate of $1.72 billion. Earnings per share came in at $0.07, matching analyst expectations and up from $0.05 in the prior-year quarter. Among its segments, Epoxy sales surged 27.5% to $422.1 million, Winchester rose 11.8% to $500.3 million, while Chlor Alkali Products and Vinyls fell 16.3% to $819.5 million. Pretax income for Winchester was $28.1 million and for Epoxy was $16 million, both exceeding analyst forecasts. The stock has gained 13.3% over the past month, compared with a 1.5% decline in the S&P 500.
Hydrochloric Acid Market to Reach USD 5.21 Billion by 2035
The global hydrochloric acid market is projected to grow from USD 2.76 billion in 2025 to USD 5.21 billion by 2035, at a compound annual growth rate of 6.03 percent, according to a report by SNS Insider. North America held the largest revenue share in 2025 at approximately 35.1 percent, with the United States contributing 87.4 percent of that regional total. The steel pickling application segment accounted for over 36.5 percent of the market in 2025, while the oil well acidizing segment was the fastest growing. Asia Pacific is expected to be the fastest-growing regional market, registering a nearly 6.4 percent CAGR from 2026 to 2035, driven by industrialization in China and India. Key players include Olin Corporation, Occidental Petroleum Corporation, Westlake Corporation, Dow Inc., and BASF SE.
BAS.XETRA · Demand · Positive Market growth driven by steel pickling and oil well acidizing increases demand for hydrochloric acid, benefiting BASF as a key producer.
DOW · Demand · Positive Market growth driven by steel pickling and oil well acidizing increases demand for hydrochloric acid, benefiting Dow as a key producer.
OLN · Demand · Positive Market growth driven by steel pickling and oil well acidizing increases demand for hydrochloric acid, benefiting Olin as a key producer.
OXY · Demand · Positive Market growth driven by steel pickling and oil well acidizing increases demand for hydrochloric acid, benefiting Occidental as a key producer.
WLK · Demand · Positive Market growth driven by steel pickling and oil well acidizing increases demand for hydrochloric acid, benefiting Westlake as a key producer.
Halper Sadeh LLC, an investor rights law firm, is investigating Simulations Plus, Huntsman Corporation, Olin Corporation, and Pulmatrix for potential violations of federal securities laws or breaches of fiduciary duties in their proposed transactions. The investigations cover Simulations Plus's sale to Altaris affiliates for $18.50 per share, Huntsman's sale to Olin for 0.5476 Olin shares per Huntsman share, Olin's merger with Huntsman where Olin shareholders would own about 54.5% of the combined company, and Pulmatrix's merger with Eos SENOLYTIX where Pulmatrix stockholders would own about 6% of the combined company. The firm may seek increased consideration, additional disclosures, or other relief on behalf of shareholders.
HUN · Capital · Negative Investigation into potential violations in Huntsman's sale to Olin may reduce deal value or impose additional costs.
OLN · Capital · Negative Investigation into Olin's merger with Huntsman may lead to increased consideration or other relief, potentially diluting Olin shareholders.
PULM · Capital · Negative Investigation into Pulmatrix's merger with Eos SENOLYTIX may seek increased consideration or additional disclosures, negatively impacting deal terms.
SLP · Capital · Negative Investigation into Simulations Plus's sale to Altaris for $18.50 per share may seek higher price or additional relief, creating uncertainty.
Plug Power sells $39.2 million investment tax credit for Louisiana hydrogen plant
Plug Power announced the sale of a federal investment tax credit for approximately $39.2 million related to its hydrogen liquefaction facility in St. Gabriel, Louisiana. The transaction is part of the company's strategy to improve liquidity and unlock value from its domestic hydrogen generation infrastructure. The St. Gabriel plant, operated through a joint venture with Olin Corporation, was commissioned in April 2025 and is one of North America's largest hydrogen liquefaction facilities. This follows a similar $30 million tax credit transfer completed in January 2025 for the company's facility in Woodbine, Georgia. Plug Power currently maintains roughly 40 tons per day of liquid hydrogen production capacity across its operational facilities in Georgia, Tennessee, and Louisiana.
Monteverde & Associates investigates mergers of Open Lending, Huntsman, Cross Country Healthcare, and Avanos Medical
Monteverde & Associates PC, a class action firm, is investigating the proposed mergers of four companies. Open Lending Corporation is being sold to ANV Group Holdings Ltd. for $3.15 per share in cash. Huntsman Corporation is being sold to Olin Corporation, with shareholders expected to receive 0.5476 shares of Olin for each Huntsman share. Cross Country Healthcare, Inc. is being sold to KL Criss Cross Intermediate, LLC for $13.25 per share in cash, with a shareholder vote scheduled for July 16, 2026. Avanos Medical, Inc. is being sold to affiliates of American Industrial Partners for $25.00 per share in cash, with a shareholder vote scheduled for July 22, 2026.
AVNS · Capital · Neutral Avanos Medical is being acquired for $25.00 per share in cash; the investigation is standard procedure and does not indicate a problem with the deal.
CCRN · Capital · Neutral Cross Country Healthcare is being acquired for $13.25 per share in cash; the investigation is standard procedure and does not indicate a problem with the deal.
HUN · Capital · Neutral Huntsman Corporation is being acquired by Olin Corporation in a stock-for-stock merger; the investigation is standard procedure and does not indicate a problem with the deal.
LPRO · Capital · Neutral Open Lending Corporation is being acquired for $3.15 per share in cash; the investigation is standard procedure and does not indicate a problem with the deal.
American Industrial Partners · Capital · Positive American Industrial Partners is acquiring Avanos Medical for $25.00 per share in cash, a positive deal for the buyer if the acquisition is accretive.
ANV Group Holdings Ltd. · Capital · Positive ANV Group Holdings Ltd. is acquiring Open Lending Corporation for $3.15 per share in cash, a positive deal for the buyer if the acquisition is accretive.
Olin Stock Could Be 16.3% Undervalued on Cost Cutting Narrative
Olin Corporation shares may be undervalued by 16.3% according to a widely followed valuation narrative, which sets a fair value of $26.29 against a recent close of $22.01. The narrative hinges on structural cost reduction initiatives, including the Beyond250 program and Epoxy cost optimization, expected to deliver $70–90 million in annual run-rate savings by the end of 2025, with additional reductions from the Stade, Germany facility in 2026. These measures are projected to improve net margins and earnings quality, supporting a future earnings multiple below many large chemicals peers. However, the thesis could be challenged if prolonged global overcapacity pressures chlor alkali pricing or if Winchester margins remain constrained by weak demand and higher input costs.
Brodsky & Smith investigates boards of AstroNova, Open Lending, Huntsman, and Standard BioTools over merger deals
Brodsky & Smith is investigating potential fiduciary duty breaches by the boards of four companies in connection with their announced mergers. AstroNova is being acquired by Arcline Investment Management for $29.00 per share in an all-cash deal valued at approximately $272 million. Open Lending is being acquired by ANV Group Holdings for $3.15 per share. Huntsman is being acquired by Olin Corporation, with Huntsman shareholders receiving 0.5476 Olin shares for each Huntsman share, resulting in Huntsman shareholders owning about 45.5% of the combined company. Standard BioTools is being acquired by Treeline Biosciences, with pre-merger Standard BioTools stockholders expected to own approximately 16% of the combined company. The investigations focus on whether the boards failed to conduct a fair process and whether the deal consideration provides fair value to shareholders.
Huntsman Fair Value Trimmed Slightly to $14.25 as Analysts Weigh Olin Merger
Analysts have modestly reduced Huntsman's fair value estimate from $14.31 to $14.25 per share, a 0.4% cut, while shifting focus to the proposed merger of equals with Olin. Mizuho upgraded Huntsman to Neutral from Underperform and raised its price target to $14 from $10, citing the combined company's more balanced profile, while Deutsche Bank lifted its target to $15 from $14 on methylene diphenyl diisocyanate market conditions. The updated valuation reflects a net profit margin adjustment to 9.10% from 9.04%, a future P/E move to 5.47x from 5.55x, and a discount rate reduction to 8.74% from 8.87%, with revenue growth held near 5.17%. Analysts note potential complementarity between Olin's U.S. gas-advantaged chlorine, caustic and ethylene position and Huntsman's differentiated downstream polyurethane and epoxy businesses, though Neutral ratings signal balanced risks around merger execution and commodity exposure.
UBS says Olin-Huntsman merger driven by cost savings, not market expansion
UBS analyst Joshua Spector said the proposed merger of equals between Olin Corp. and Huntsman Corp. appears driven primarily by vertical integration and cost-saving opportunities rather than expansion into new end markets. The companies expect to achieve $300 million in annual cost savings by the end of the third year following the merger, with an additional $100 million opportunity available after the expiration of an Olin supply contract in 2031. UBS estimated that capitalizing the initial $300 million in annual savings at roughly six times could generate about $8 per share of value, rising to approximately $11 per share if the full $400 million of savings is realized. The projected synergies include roughly $75 million from procurement and raw-material savings, $75 million from operational efficiencies, and $150 million from reductions in selling, general and administrative expenses. Under the terms of the agreement, Huntsman shareholders would receive 0.5476 Olin shares for each Huntsman share they own, with the combined company owned approximately 54.5% by Olin shareholders and 45.5% by Huntsman shareholders.
Olin and Huntsman to merge in all-stock deal, forming $12.5 billion chemicals leader
Olin Corporation and Huntsman Corporation have signed a definitive agreement to combine in an all-stock merger of equals, creating a new company named OlinHuntsman Corporation. The combined entity will have 2025 revenues of approximately $12.5 billion and a global manufacturing footprint across North America, Europe, and Asia. Under the terms, Huntsman shareholders will receive 0.5476 shares of Olin for each HUN share they own, with existing Olin shareholders expected to own about 54.5% of the combined company and Huntsman shareholders the remaining 45.5%. The companies have identified more than $400 million in total cost synergies and integration benefits, including over $300 million in cost synergies expected to be largely realized within 24 months and an additional $100 million in raw material integration benefits beginning in 2031. The transaction, unanimously approved by both boards, is expected to close in the first half of 2027, subject to shareholder and regulatory approvals.
Huntsman Corporation shares plunged 17.1% after Olin Corporation agreed to acquire the company in an all-stock transaction valued at $2.43 billion, with the deal's discounted valuation weighing on the stock. Yum! Brands shares rose 1.9% after the company announced plans to sell its Pizza Hut chain for $2.7 billion. Space Exploration Technologies shares rose 4.8%, extending their post-IPO rally and briefly overtaking Amazon.com in market capitalization. NVIDIA shares fell 2.4% amid a broader decline in the technology sector.
USA